Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 117

Results For "EMS"

1524 News Found

IGSTC to propose joint AI initiative on healthcare and sustainability
Sustainability | May 05, 2022

IGSTC to propose joint AI initiative on healthcare and sustainability

This agreement is truly remarkable for achieving greater objectives in the projects and addressing larger problems


Promising new universal coronavirus vaccine candidate discovered
News | May 05, 2022

Promising new universal coronavirus vaccine candidate discovered

Formula attenuates 99% of 365 coronaviruses in computer models


Mediso acquires nuclear medicine supplier Bartec Technologies
Biotech | May 05, 2022

Mediso acquires nuclear medicine supplier Bartec Technologies

In the UK, Bartec has been synonymous with Mediso products for 18 years, proof of a successful partnership


Israeli researchers warn about the return of Delta variant
News | May 05, 2022

Israeli researchers warn about the return of Delta variant

The research was supported by the BGU Coronavirus Challenge and the Israeli Ministry of Health.


14.9 million excess deaths associated with the Covid-19 pandemic in 2020 and 2021
News | May 05, 2022

14.9 million excess deaths associated with the Covid-19 pandemic in 2020 and 2021

The report has estimated 4.74 million deaths for India in 2020 and 2021,


Scipio bioscience announces its revolutionary Asteria single-cell RNA-seq kit
Biotech | May 04, 2022

Scipio bioscience announces its revolutionary Asteria single-cell RNA-seq kit

At an affordable price, a researcher can process fresh samples of 10,000 cells immediately with a stable stopping point within two hours, simplifying sample management at the laboratory and limiting transcriptional changes


Philips and Prisma Health sign multi-year, long-term strategic partnership
Digitisation | April 29, 2022

Philips and Prisma Health sign multi-year, long-term strategic partnership

South Carolina’s largest health system adopts Philips software solutions for patient monitoring and enterprise imaging, helping to drive interoperability and data analytics, and deliver on Quadruple Aim


Camzyos is the first and only USFDA-approved cardiac myosin inhibitor
Biotech | April 29, 2022

Camzyos is the first and only USFDA-approved cardiac myosin inhibitor

Approval based on groundbreaking Phase 3 EXPLORER-HCM trial demonstrating benefit in patients receiving Camzyos versus placebo


AstraZeneca expands its ‘Young Health Program’ in Delhi
Public Health | April 29, 2022

AstraZeneca expands its ‘Young Health Program’ in Delhi

For over a decade, AstraZeneca and Plan India’s Young Health Program have been generating awareness and identifying sustainable solutions to influence the behaviour of youths against Non-Communicable Diseases


Ceryx Medical raises £3.8m in seed funding to bring cardiac device to in-human trials
Startup | April 28, 2022

Ceryx Medical raises £3.8m in seed funding to bring cardiac device to in-human trials

Cysoni is a bionic device that paces the heart with real-time respiratory modulation